Los Angeles Capital Management’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
AIM
Los Angeles Capital Management's VCYT Position: Q2 2026 in Review
Los Angeles Capital Management reduced its Veracyte (VCYT) stake by 24% in Q2 2026, selling an estimated $915K and leaving 69,585 shares worth $4.09M. The position accounts for 0.02% of the portfolio, ranked #456.
Los Angeles Capital Management first reported a position in VCYT in Q4 2018 and has held it in 20 quarters since. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.
- Los Angeles Capital Management held 69,585 shares of Veracyte worth $4.09M as of Q2 2026.
- Los Angeles Capital Management sold 21,816 Veracyte shares in Q2 2026, an estimated $915K.
- Veracyte made up 0.02% of Los Angeles Capital Management's portfolio in Q2 2026, its #456 holding.
- Los Angeles Capital Management first reported a position in Veracyte in Q4 2018 and has held it in 20 quarters since.
- 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.
Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.